A lawsuit brought by the Kentucky Attorney General alleging that Janssen Pharmaceuticals, the manufacturer of the antipsychotic drug Risperdal, marketed the medication as an appropriate treatment for dementia in non-schizophrenic elderly patients has been settled for $15.5 million.
According to court documents, Janssen Pharmaceuticals even went so far as to establish an elder care sales force, despite the fact that the company’s own study conducted in 1997 showed that Risperdal actually doubled the risk of death among the elderly.
Risperdal’s label did not disclose this risk to the public until 2003, and in 2013, Janssen pleaded guilty to federal charges of misbranding the drug regarding the promotions to the elderly.
The lawsuit alleged that Janssen did not disclose the risks associated with Risperdal to consumers, and also marketed the drug for uses other than those that were originally approved by the U.S. Food and Drug Administration (FDA), resulting in excessive costs to Medicare and Medicaid in the state.
Risperdal is an anti-psychotic drug first approved by the U.S. Food and Drug Administration in 1993 to treat adults with schizophrenia.
In 2006 and 2007, the FDA approved additional uses for Risperdal, including the treatment of bipolar disorder in adults and juveniles, schizophrenia in children, and certain behavioral symptoms in children with autism.
The Kentucky lawsuit alleged that even though Risperdal was approved for use in children with Attention Deficit Hyperactivity Disorder (ADHD) in 2007, Janssen actively marketed Risperdal to children and the youth market long before the medication was formally approved for that category of patients.
One Risperdal side effect that has occurred in young males is Risperdal gynecomastia, the development of male breasts stemming from a hormonal imbalance triggered by Risperdal.
Risperdal lawsuits brought by males who claim that their Risperdal prescription caused them to develop gynecomastia continue to be filed and move through courts across the U.S.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.
Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.
Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
The FDA is warning consumers that Unomedical A/S’s October 11, 2023 recall of its VariSoft Infusion Sets has been labeled Class I, the most serious type, because use of the device could result in major injuries or death. The recall covers 13,069 boxes of VariSoft
According to the FDA, the Pennsylvania Department of Agriculture is warning consumers that certain “Hilltop Meadow Farm”-branded “60 Day Aged Pepper Jack Raw Milk Cheese” should be disposed of due to the potential presence of the bacteria Listeria monocytogenes. Though Listeria in healthy individuals may
Fresno, California-based Jewel Marketing and Agribusiness LLC (dba Crown Jewels Produce) has recalled 1,960 boxes of whole cantaloupes under the Malichita / Z Farms label because they may be contaminated with Salmonella, according to the FDA. While healthy people infected with Salmonella may only experience